BET proteins became promising therapeutic candidates for the treatment of inflammation and cancer with the invention of numerous small chemical inhibitors that were specifically bound to BET bromo domains, such as benzodiazepine derivatives, I-BETs, and JQ1 [38–41]. Here, DNER is linked to cancer.